Search research articles
Contact Us
Filters
Showing results (41-50 of 83) with videos related to
Page
of 9
Sort By:
The Quarterly Journal of Medicine
|
January 1, 1984
The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction
R A Evans, E Hills, S Y Wong, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 1, 1999
A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3
S Morony, C Capparelli, R Lee, et al.
Bone
|
September 24, 1999
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells
L C Hofbauer, D L Lacey, C R Dunstan, et al.
Endocrinology
|
August 28, 1999
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells
L C Hofbauer, S Khosla, C R Dunstan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
January 26, 2000
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
L C Hofbauer, S Khosla, C R Dunstan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2001
Serum osteoprotegerin levels are increased in patients with advanced prostate cancer
J M Brown, R L Vessella, P J Kostenuik, et al.
Bone
|
May 5, 2005
Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats
A Valenta, P Roschger, N Fratzl-Zelman, et al.
Biochemical and Biophysical Research Communications
|
February 13, 2001
Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells
L C Hofbauer, C Shui, B L Riggs, et al.
Bone
|
April 25, 2000
Osteoprotegerin mitigates tail suspension-induced osteopenia
T A Bateman, C R Dunstan, V L Ferguson, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
August 24, 2001
Osteoprotegerin ameliorates sciatic nerve crush induced bone loss
T A Bateman, C R Dunstan, D L Lacey, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 83) with videos related to
Sort By:
Page
of 9
The Quarterly Journal of Medicine
|
January 1, 1984
The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction
R A Evans, E Hills, S Y Wong, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 1, 1999
A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3
S Morony, C Capparelli, R Lee, et al.
Bone
|
September 24, 1999
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells
L C Hofbauer, D L Lacey, C R Dunstan, et al.
Endocrinology
|
August 28, 1999
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells
L C Hofbauer, S Khosla, C R Dunstan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
January 26, 2000
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
L C Hofbauer, S Khosla, C R Dunstan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2001
Serum osteoprotegerin levels are increased in patients with advanced prostate cancer
J M Brown, R L Vessella, P J Kostenuik, et al.
Bone
|
May 5, 2005
Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats
A Valenta, P Roschger, N Fratzl-Zelman, et al.
Biochemical and Biophysical Research Communications
|
February 13, 2001
Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells
L C Hofbauer, C Shui, B L Riggs, et al.
Bone
|
April 25, 2000
Osteoprotegerin mitigates tail suspension-induced osteopenia
T A Bateman, C R Dunstan, V L Ferguson, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
August 24, 2001
Osteoprotegerin ameliorates sciatic nerve crush induced bone loss
T A Bateman, C R Dunstan, D L Lacey, et al.
Page
of 9